background preloader

Escherichia coli résistants aux antibiotiques

Facebook Twitter

Journal of Taibah University Medical Sciences Volume 10, Issue 4, December 2015, Prevalence of fluoroquinolone resistance in Escherichia coli in an Indian teaching hospital and adjoining communities. Journal of Global Antimicrobial Resistance Volume 3, Issue 4, December 2015, First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals. ECDC 25/11/16 Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe. ​The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.

ECDC 25/11/16 Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Europe

It results in higher healthcare costs, prolonged hospital stays, treatment failures and sometimes death. In 2012, the European Centre for Disease Prevention and Control (ECDC) launched the the “European Survey on Carbapenamase-Producing Enterobacteriaceae''' (EuSCAPE) project with the aim to gather data on the occurrence of CPE in Europe and build laboratory capacity for their diagnosis and for surveillance.

The surve​y showed that on average in Europe, 1.3 patients per 10 000 hospital admissions had a carbapenemase-producing K. pneumoniae or E. coli infection, with the highest incidence found in southern and southeastern Europe. In K. pneumoniae, the most frequently detected carbapenamases were KPC enzymes, followed by OXA-48-like, NDM and VIM, while in E. coli, there were OXA-48-like enzymes followed by NDM and KPC. CDC EID - Volume 22, Number 9—September 2016. Au sommaire notamment: Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase–Producing Escherichia coli Infections in Patients with Pyelonephritis, United States.

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

CDC EID - Volume 22, Number 9—September 2016. Au sommaire notamment: Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase–Producing Escherichia coli Infections in Patients with Pyelonephritis, United States

This activity has been planned and implemented through the joint providership of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. Release date: August 12, 2016; Expiration date: August 12, 2017 Learning Objectives CME Editor CME Author Charles P.

Authors. BLOG D ALBERT AMGAR 27/07/16 Des chercheurs allemands identifient 402 isolats comportant le gène mcr-1. « Des chercheurs allemands identifient 402 isolats comportant le gène mcr-1 », source CIDRAPS News. 10,7% des isolats de dinde et 5,6% des isolats de poulets de chair testés positifs pour le gène mcr-1.

BLOG D ALBERT AMGAR 27/07/16 Des chercheurs allemands identifient 402 isolats comportant le gène mcr-1.

Des chercheurs en Allemagne ont déclaré le 25 juillet 2016 avoir trouvé plus de 400 isolats de Escherichia coli provenant de troupeaux et de produits alimentaires qui ont été testés positifs pour le gène mcr-1, ce qui peut rendre les bactéries résistantes au puissant antibiotique, la colistine. Publiant dans PLoS One, les chercheurs ont rapporté que le sreening a détecté mcr-1 chez 402 sur 505 (79,8%) isolats de E. coli résistants à la colistine dans le cadre d’un programme allemand de surveillance de la résistance aux antibiotiques chez les agents zoonotiques.

Les chercheurs ont dit que l’étude, qui a examiné plus de 10 000 isolats de E. coli réunis provenant de troupeaux et d’aliments allemands de 2010-2015, est le premier regard systématique sur la prévalence du gène mcr-1 dans le pays. FRONTIERS IN MICROBIOLOGY 04/03/16 Emergence of Hyper-Resistant Escherichia coli MG1655 Derivative Strains after Applying Sub-Inhibitory Doses of Individual Constituents of Essential Oils. Global Veterinaria 10 (4): 447-452, 2013 Antibioresistance Profile of Avian pathogenic Escherichia coli Isolates Recovered from. BMC Microbiology 2013, 13:84 Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum be. J Vet Adv 2012, 2(5): 209-215 Antimicrobial Resistant pattern of E. coli O157 Isolated from Human, Cattle and Surface Water Samp. CDC EID - MAI 2012 - Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002.

Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options CDC Home CDC 24/7: Saving Lives.

CDC EID - MAI 2012 - Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002

Protecting People. Braz. J. Microbiol. vol.42 no.2 São Paulo Apr./June 2011 Prevalence of antimicrobial resistance and integrons in Escherichia Col. JOURNAL OF ANIMAL AND VETERINARY ADVANCES - 2011 - Antimicrobial resistance and resistance gene determinants of fecal escherichi. Escherichia coli résistant aux fluoroquinolones. MICROBIOLOGY JOURNAL - 2011 - Escherichia coli, it prevalence and antibiotic resistant in Malaysia: A mini review. Role of Antimicrobial Selective Pressure and Secondary Factors on Antimicrobial Resistance Prevalence in Escherichia coli from Food-Producing Animals in Japan.

Autres articles scientifiques et techniques

Gène mcr-1 résistant à la colistine. Méthodes de détection de l'antibiorésistance chez E. coli. Dans l'environnement. Escherichia coli résistants aux antib. - Secteur vétérinaire. Santé humaine. Actualités concernant ST 131. Multi-resistant Escherichia coli and mycotic aneurysm: two case reports. Case 1 A 69-year-old man was admitted in August 2005, following a six hour history of suprapubic pain, fever and rigors.

Multi-resistant Escherichia coli and mycotic aneurysm: two case reports

He had a long term catheter for a prostate problem and his past history included a myocardial infarction in 2001, followed by a series of small strokes. As a result of these, he had a mild residual left hemiparesis and had received a stent to his right carotid artery. On examination he was pyrexial (39.2°C) with otherwise normal vital signs and no new findings. Investigations showed a low white cell count (2.5 × 109/litre) and raised inflammatory markers, with an ESR of 84 mm/hr and C-reactive protein of 176 mg/l. Cultures of blood and urine grew E. coli resistant to all cephalosporins and fluoroquinolones but susceptible to meropenem. A computed tomography (CT) scan was requested to explore the possibility of lymphoma or a deep abscess. Figure 1. Figure 2. Figure 3. Case 2 At day 44, he developed a swelling on the right side of his neck. Microbiological typing. Las granjas de pollos y de cerdos, un riesgo potencial de <i>Escherichia coli</i> UAB Barcelona.

Antibiotics.pdf (Objet application/pdf) Gay_AntimicrobialResistanceEColi.pdf (Objet application/pdf) Cephalosporin resistance mechanisms in Escherichia... [J Antimicrob Chemother. 2010] - PubMed result. 340506. Escherichia coli résistants aux céphalosporines. Escherichia coli résistant aux fluoroquinolones.